Latest article
Diabetes drug considerably cuts physique weight in adults with weight problems
A phase 3 clinical study published in the New England Journal of Medicine showed an average 14.9% decrease in body weight in obese or...
Section III Trial Reveals Lilly’s Tirzepatide is Superior to Rival in Kind 2 Diabetes
Jonathan Weiss / Shutterstock
Eli Lillys The Phase III SURPASS 2 clinical trial shows treatment with tirzepatide, a once-weekly dual glucose-dependent insulinotropic polypeptide and glucagon-like...